CD8A and neoplasm: Significantly fewer CD45.2+ cells were found in the tumor of mice receiving STZ-diabetic P14 CD8+ effector cells than STZ-non-diabetic group (Figure 4B), STZ-diabetic: 24.8, 95% confidence interval (CI), 14.8–34.8; STZ-non-diabetic: 43.7, 95% CI, 34.4–52.9; p<0.01.